Advertisement
Screener

OUTLOOK THERAPEUTICS, INC. (OTLK) Secured Debt

OUTLOOK THERAPEUTICS, INC. Secured Debt

OUTLOOK THERAPEUTICS, INC. (OTLK) had Secured Debt of $7.80 million as of 2020-03-31, per its 10-Q filed 2020-05-15.

Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified

us-gaap:SecuredDebt · last filed 2020-05-15

  • 2020-03-31: Secured Debt $7.80M.
  • 2019-12-31: Secured Debt $7.60M.
  • 2019-06-30: Secured Debt $6.70M.
  • 2019-03-31: Secured Debt $8.50M.
Period endSecured Debt
2020-03-31$7.80M
10-Q · filed 2020-05-15
2019-12-31$7.60M
10-Q · filed 2020-02-14
2019-06-30$6.70M
10-Q · filed 2019-08-14
2019-03-31$8.50M
10-Q · filed 2019-05-15
2018-12-31$10.40M
10-Q · filed 2019-02-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Acumen Pharmaceuticals, Inc. (ABOS)United States$0.162B-1.83
Humacyte, Inc. (HUMA)United States$0.155B-2.26
Voyager Therapeutics, Inc. (VYGR)United States$0.173B-1.99
PRECISION BIOSCIENCES INC (DTIL)United States$0.175B-3.95
Coherus Oncology, Inc. (CHRS)United States$0.182B-1.63
Tenaya Therapeutics, Inc. (TNYA)United States$0.140B-1.60
Alpha Cognition Inc. (ACOG)$0.185B-6.77
Caribou Biosciences, Inc. (CRBU)United States$0.134B-1.79
Armata Pharmaceuticals, Inc. (ARMP)United States$0.132B
Neumora Therapeutics, Inc. (NMRA)United States$0.132B-1.48